Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance

Journal of Biological Chemistry

Volumn 287, Issue 53, 2012, Pages 44714-44735

  Bachu, Mahesh ^a   Yalla, Swarupa ^a   Asokan, Mangaiarkarasi ^a   Verma, Anjali ^a   Neogi, Ujjwal ^b   Sharma, Shilpee ^a   Murali, Rajesh V ^a   Mukthey, Anil Babu ^a   Bhatt, Raghavendra ^c   Chatterjee, Snehajyoti ^a   Rajan, Roshan Elizabeth ^a   Cheedarla, Narayana ^a   Yadavalli, Venkat S ^d   Mahadevan, Anita ^e   Shankar, Susarla K ^e   Rajagopalan, Nirmala ^c   Shet, Anita ^b   Saravanan, Shanmugam ^f   Balakrishnan, Pachamuthu ^f   Solomon, Suniti ^f   Vajpayee, Madhu ^g   Satish, Kadappa Shivappa ^h   Kundu, Tapas K ^a   Jeang, Kuan Teh ^d   Ranga, Udaykumar ^a   more..

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^c Freedom Foundation   (India)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^h Chest and Maternity Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL EVIDENCE; GLOBAL REGIONS; HETERODIMERS; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEATS; MOUSE MODELS; POPULATION LEVELS; PRIMARY CELLS; SOUTH AFRICA; TRANSCRIPTION INITIATION; VIRAL LOAD; VIRAL PROMOTERS;

CELL CULTURE; TRANSCRIPTION; TRANSCRIPTION FACTORS;

VIRUSES;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; LONG TERMINAL REPEAT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; VIRUS LOAD; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TRANSCRIPTION;

ADULT; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN BINDING; TRANSCRIPTION, GENETIC; VIRUS REPLICATION; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871772179     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.397158     Document Type: Article

References (73)

1. Tebit, D. M., and Arts, E. J. (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 11, 45-56
2. Hemelaar, J., Gouws, E., Ghys, P. D., and Osmanov, S. (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25, 679-689
3. Bongertz, V., Bou-Habib, D. C., Brígido, L. F., Caseiro, M., Chequer, P. J., Couto-Fernandez, J. C., Ferreira, P. C., Galvão-Castro, B., Greco, D., Guimarães, M. L., Linhares de Carvalho, M. I., Morgado, M. G., Oliveira, C. A., Osmanov, S., Ramos, C. A., Rossini, M., Sabino, E., Tanuri, A., and Ueda, M. (2000) HIV-1 diversity in Brazil. Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization. J. Acquir. Immune. Defic. Syndr. 23, 184-193
4. Soares, M. A., De Oliveira, T., Brindeiro, R. M., Diaz, R. S., Sabino, E. C., Brigido, L., Pires, I. L., Morgado, M. G., Dantas, M. C., Barreira, D., Teixeira, P. R., Cassol, S., and Tanuri, A. (2003) A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 17, 11-21
5. Locateli, D., Stoco, P. H., de Queiroz, A. T., Alcântara, L. C., Ferreira, L. G., Zanetti, C. R., Rodrigues, R., Grisard, E. C., and Pinto, A. R. (2007) Molecular epidemiology of HIV-1 in Santa Catarina State confirms increases of subtype C in Southern Brazil. J. Med. Virol. 79, 1455-1463
6. Ranga, U., Banerjea, A., Chakrabarti, S., and Mitra, D. (2010) HIV/AIDS research in India-past, present, and future. Curr. Sci. 98, 335-345
7. De Baar, M. P., De Ronde, A., Berkhout, B., Cornelissen, M., Van Der Horn, K. H., Van Der Schoot, A. M., De Wolf, F., Lukashov, V. V., and Goudsmit, J. (2000) Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res. Hum. Retroviruses 16, 499-504
8. Hunt, G., and Tiemessen, C. T. (2000) Occurrence of additional NF-κB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates. AIDS Res. Hum. Retroviruses 16, 305-306
9. Munkanta, M., Handema, R., Kasai, H., Gondwe, C., Deng, X., Yamashita, A., Asagi, T., Yamamoto, N., Ito, M., Kasolo, F., and Terunuma, H. (2005) Predominance of three NF-κB-binding sites in the long terminal repeat region of HIV type 1 subtype C isolates from Zambia. AIDS Res. Hum. Retroviruses 21, 901-906
10. Naghavi, M. H., Schwartz, S., Sönnerborg, A., and Vahlne, A. (1999) Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res. Hum. Retroviruses 15, 1293-1303
11. Jeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K., and Berkhout, B. (2000) Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74, 3740-3751
12. Montano, M. A., Novitsky, V. A., Blackard, J. T., Cho, N. L., Katzenstein, D. A., and Essex, M. (1997) Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 71, 8657-8665
13. Ramírez de Arellano E., Soriano, V., Alcamil, J., and Holguín, A. (2006) New findings on transcription regulation across different HIV-1 subtypes. AIDS Rev. 8, 9-16
14. Verhoef, K., Sanders, R. W., Fontaine, V., Kitajima, S., and Berkhout, B. (1999) Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-κB enhancer element into a GABP-binding site. J. Virol. 73, 1331-1340
15. Björndal, A., Sönnerborg, A., Tscherning, C., Albert, J., and Fenyö, E. M. (1999) Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retroviruses 15, 647-653
16. Naghavi, M. H., Salminen, M. O., Sönnerborg, A., and Vahlne, A. (1999) DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G. AIDS Res. Hum. Retroviruses 15, 485-488
17. Hunt, G. M., Johnson, D., and Tiemesse, C. T. (2001) Characterisation of the long terminal repeat regions of South African human immunodeficiency virus type 1 isolates. Virus Genes 23, 27-34
18. Johansson, B., Sherefa, K., and Sönnerborg, A. (1995) Multiple enhancer motifs in HIV type 1 strains from Ethiopia. AIDS Res. Hum. Retroviruses 11, 761-764
19. Scriba, T. J., Treurnicht, F. K., Zeier, M., Engelbrecht, S., and van Rensburg, E. J. (2001) Characterization and phylogenetic analysis of South African HIV-1 subtype c accessory genes. AIDS Res. Hum. Retroviruses 17, 775-781
20. Papathanasopoulos, M. A., Cilliers, T., Morris, L., Mokili, J. L., Dowling, W., Birx, D. L., and McCutchan, F. E. (2002) Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS Res. Hum. Retroviruses 18, 879-886
21. Gao, F., Robertson, D. L., Morrison, S. G., Hui, H., Craig, S., Decker, J., Fultz, P. N., Girard, M., Shaw, G. M., Hahn, B. H., and Sharp, P. M. (1996) The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J. Virol. 70, 7013-7029
22. Estable, M. C. (2007) In search of a function for the most frequent naturally occurring length polymorphism (MFNLP) of the HIV-1 LTR. Retaining functional coupling, of Nef and RBF-2, at RBEIII? Int. J. Biol. Sci. 3, 318-327
23. Estable, M. C., Bell, B., Hirst, M., and Sadowski, I. (1998) Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J. Virol. 72, 6465-6474
24. Estable, M. C., Bell, B., Merzouki, A., Montaner, J. S., O'Shaughnessy, M. V., and Sadowski, I. J. (1996) Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J. Virol. 70, 4053-4062
25. Siddappa, N. B., Dash, P. K., Mahadevan, A., Desai, A., Jayasuryan, N., Ravi, V., Satishchandra, P., Shankar, S. K., and Ranga, U. (2005) Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India. AIDS 19, 1426-1429
26. Bachu, M., Mukthey, A. B., Murali, R. V., Cheedarla, N., Mahadevan, A., Shankar, S. K., Satish, K. S., Kundu, T. K., and Ranga, U. (2012) Sequence insertions in the HIV-1 subtype C viral promoter predominantly generate an additional NF-κB-binding site. AIDS Res. Hum. Retroviruses 28, 1362-1368
27. Asokan, M., Imtiaz, N. L., Anilbabu, M., Siddhartha, P., Gayathri, M., Praveen, K. K., Satish, B., Eugene, W., Sahayam, S., Gopinath, V., Rajalakshmi, P., Karthikeyan, B., Devanathan, R., Ravichandran, M., Mariamma, P., Ravindra, K. C., Jeelan, N. B., Pushpak, M., Gurvinder, K., Narinder, K. M., Kundu, T. K., Subbakrishna, D. K., Satish, K. S., and Ranga, U. (2012) Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation. Indian J. Med. Res., in press
28. Sambrook, J., and Russel, D. W. (2001) Molecular Cloning: A Laboratory Manual, 3rd Ed., pp. 5.51-5.54, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. Perkins, N. D., Agranoff, A. B., Pascal, E., and Nabel, G. J. (1994) An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14, 6570-6583
30. Kaminuma, O., Kitamura, F., Kitamura, N., Hiroi, T., Miyoshi, H., Miyawaki, A., and Miyatake, S. (2008) Differential contribution of NFATc2 and NFATc1 to TNF-α gene expression in T cells. J. Immunol. 180, 319-326
31. Jordan, M., Schallhorn, A., and Wurm, F. M. (1996) Transfecting mammalian cells. Optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24, 596-601
32. Ariën, K. K., Abraha, A., Quiñones-Mateu, M. E., Kestens, L., Vanham, G., and Arts, E. J. (2005) The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79, 8979-8990
33. Siddappa, N. B., Dash, P. K., Mahadevan, A., Jayasuryan, N., Hu, F., Dice, B., Keefe, R., Satish, K. S., Satish, B., Sreekanthan, K., Chatterjee, R., Venu, K., Satishchandra, P., Ravi, V., Shankar, S. K., Shankarappa, R., and Ranga, U. (2004) Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J. Clin. Microbiol. 42, 2742-2751
34. Rousseau, C. M., Birditt, B. A., McKay, A. R., Stoddard, J. N., Lee, T. C., McLaughlin, S., Moore, S. W., Shindo, N., Learn, G. H., Korber, B. T., Brander, C., Goulder, P. J., Kiepiela, P., Walker, B. D., and Mullins, J. I. (2006) Large scale amplification, cloning, and sequencing of near full-length HIV-1 subtype C genomes. J. Virol. Methods 136, 118-125
35. Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., and Schaffer, D. V. (2005) Stochastic gene expression in a lentiviral positive-feedback loop. HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122, 169-182
36. Phatnani, H. P., and Greenleaf, A. L. (2006) Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 20, 2922-2936
37. Siddappa, N. B., Kashi, V. P., Venkatramanan, M., Balasiddaiah, A., Jayasuryan, N., Mahadevan, A., Desai, A., Satish, K. S., Shankar, S. K., Ravi, V., and Ranga, U. (2007) Gene expression analysis from human immunodeficiency virus type-1 subtype C promoter and construction of bicistronic reporter vectors. AIDS Res. Hum. Retroviruses 23, 1268-1278
38. + T cells. Blood 113, 58-65
39. Potash, M. J., Chao, W., Bentsman, G., Paris, N., Saini, M., Nitkiewicz, J., Belem, P., Sharer, L., Brooks, A. I., and Volsky, D. J. (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc. Natl. Acad. Sci. U.S.A. 102, 3760-3765
40. Hadas, E., Borjabad, A., Chao, W., Saini, M., Ichiyama, K., Potash, M. J., and Volsky, D. J. (2007) Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1. AIDS 21, 905-909
41. Saini, M., Hadas, E., Volsky, D. J., and Potash, M. J. (2007) Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3. Vaccine 25, 8660-8663
42. Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., and Gray, R. H. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N. Engl. J. Med. 342, 921-929
43. Garcia, P. M., Kalish, L. A., Pitt, J., Minkoff, H., Quinn, T. C., Burchett, S. K., Kornegay, J., Jackson, B., Moye, J., Hanson, C., Zorrilla, C., and Lew, J. F. (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and infants transmission study group. N. Engl. J. Med. 341, 394-402
44. Englund, G., Hoggan, M. D., Theodore, T. S., and Martin, M. A. (1991) A novel HIV-1 isolate containing alterations affecting the NF-κB element. Virology 181, 150-157
45. Parrott, C., Seidner, T., Duh, E., Leonard, J., Theodore, T. S., Buckler-White, A., Martin, M. A., and Rabson, A. B. (1991) Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes. J. Virol. 65, 1414-1419
46. Zhang, L., Huang, Y., Yuan, H., Chen, B. K., Ip, J., and Ho, D. D. (1997) Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1α region but lacking NF-κB-binding sites. J. Virol. 71, 1651-1656
47. Ross, E. K., Buckler-White, A. J., Rabson, A. B., Englund, G., and Martin, M. A. (1991) Contribution of NF-κB- and Sp1-binding motifs to the replicative capacity of human immunodeficiency virus type 1. Distinct patterns of viral growth are determined by T-cell types. J. Virol. 65, 4350-4358
48. Leonard, J., Parrott, C., Buckler-White, A. J., Turner, W., Ross, E. K., Martin, M. A., and Rabson, A. B. (1989) The NF-κB-binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63, 4919-4924
49. Michael, N. L., D'Arcy, L., Ehrenberg, P. K., and Redfield, R. R. (1994) Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J. Virol. 68, 3163-3174
50. Koken, S. E., van Wamel, J. L., Goudsmit, J., Berkhout, B., and Geelen, J. L. (1992) Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191, 968-972
51. Montano, M. A., Nixon, C. P., Ndung'u, T., Bussmann, H., Novitsky, V. A., Dickman, D., and Essex, M. (2000) Elevated tumor necrosis factor-α activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-κB enhancer gain-of-function. J. Infect. Dis. 181, 76-81
52. van Opijnen, T., Jeeninga, R. E., Boerlijst, M. C., Pollakis, G. P., Zetterberg, V., Salminen, M., and Berkhout, B. (2004) Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J. Virol. 78, 3675-3683
53. Fusuma, E. E., Caruso, S. C., Lopez, D. F., Costa, L. J., Janini, L. M., De Mendonça, J. S., Kallas, E. G., and Diaz, R. S. (2005) Duplication of peri-κB and NF-κB sites of the first human immunodeficiency virus type 2 (HIV-2) transmission in Brazil. AIDS Res. Hum. Retroviruses 21, 965-970
54. Ilyinskii, P. O., and Desrosiers, R. C. (1996) Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-κB- and Sp1-binding elements. J. Virol. 70, 3118-3126
55. Pöhlmann, S., Flöss, S., Ilyinskii, P. O., Stamminger, T., and Kirchhoff, F. (1998) Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-κB- and Sp1-binding elements. J. Virol. 72, 5589-5598
56. Lemieux, A. M., Paré, M. E., Audet, B., Legault, E., Lefort, S., Boucher, N., Landry, S., van Opijnen, T., Berkhout, B., Naghavi, M. H., Tremblay, M. J., and Barbeau, B. (2004) T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-κB and NFAT with its enhancer region. J. Biol. Chem. 279, 52949-52960
57. Roof, P., Ricci, M., Genin, P., Montano, M. A., Essex, M., Wainberg, M. A., Gatignol, A., and Hiscott, J. (2002) Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-κB and the Tat transactivator. Virology 296, 77-83
58. Siggers, T., Chang, A. B., Teixeira, A., Wong, D., Williams, K. J., Ahmed, B., Ragoussis, J., Udalova, I. A., Smale, S. T., and Bulyk, M. L. (2012) Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding. Nat. Immunol. 13, 95-102
59. Fraser, C., Hollingsworth, T. D., Chapman, R., de Wolf, F., and Hanage, W. P. (2007) Variation in HIV-1 set-point viral load. Epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U.S.A. 104, 17441-17446
60. Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., Wei, X., Jiang, C., Kirchherr, J. L., Gao, F., Anderson, J. A., Ping, L. H., Swanstrom, R., Tomaras, G. D., Blattner, W. A., Goepfert, P. A., Kilby, J. M., Saag, M. S., Delwart, E. L., Busch, M. P., Cohen, M. S., Montefiori, D. C., Haynes, B. F., Gaschen, B., Athreya, G. S., Lee, H. Y., Wood, N., Seoighe, C., Perelson, A. S., Bhattacharya, T., Korber, B. T., Hahn, B. H., and Shaw, G. M. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 105, 7552-7557
61. Salazar-Gonzalez, J. F., Salazar, M. G., Keele, B. F., Learn, G. H., Giorgi, E. E., Li, H., Decker, J. M., Wang, S., Baalwa, J., Kraus, M. H., Parrish, N. F., Shaw, K. S., Guffey, M. B., Bar, K. J., Davis, K. L., Ochsenbauer-Jambor, C., Kappes, J. C., Saag, M. S., Cohen, M. S., Mulenga, J., Derdeyn, C. A., Allen, S., Hunter, E., Markowitz, M., Hraber, P., Perelson, A. S., Bhattacharya, T., Haynes, B. F., Korber, B. T., Hahn, B. H., and Shaw, G. M. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206, 1273-1289
62. Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., and Victorino, R. M. (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169, 3400-3406
63. Aboul-ela, F., Karn, J., and Varani, G. (1996) Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res. 24, 3974-3981
64. Burnett, J. C., Miller-Jensen, K., Shah, P. S., Arkin, A. P., and Schaffer, D. V. (2009) Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog. 5, e1000260
65. Quiñones-Mateu, M. E. (2005) Is HIV-1 evolving to a less virulent (pathogenic) virus? AIDS 19, 1689-1690
66. Ariën, K. K., Vanham, G., and Arts, E. J. (2007) Is HIV-1 evolving to a less virulent form in humans? Nat. Rev. Microbiol. 5, 141-151
67. Ranga, U., Shankarappa, R., Siddappa, N. B., Ramakrishna, L., Nagendran, R., Mahalingam, M., Mahadevan, A., Jayasuryan, N., Satishchandra, P., Shankar, S. K., and Prasad, V. R. (2004) Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J. Virol. 78, 2586-2590
68. Mishra, M., Vetrivel, S., Siddappa, N. B., Ranga, U., and Seth, P. (2008) Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons. Significance of dicysteine C30C31 motif. Ann. Neurol. 63, 366-376
69. Rao, V. R., Sas, A. R., Eugenin, E. A., Siddappa, N. B., Bimonte-Nelson, H., Berman, J. W., Ranga, U., Tyor, W. R., and Prasad, V. R. (2008) HIV-1 clade-specific differences in the induction of neuropathogenesis. J. Neurosci. 28, 10010-10016
70. Gandhi, N., Saiyed, Z., Thangavel, S., Rodriguez, J., Rao, K. V., and Nair, M. P. (2009) Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and anti-inflammatory cytokines by primary monocytes. AIDS Res. Hum. Retroviruses 25, 691-699
71. Campbell, G. R., Watkins, J. D., Singh, K. K., Loret, E. P., and Spector, S. A. (2007) The human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J. Virol. 81, 5919-5928
72. Wong, J. K., Campbell, G. R., and Spector, S. A. (2010) Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. J. Biol. Chem. 285, 18319-18325
73. Mellors, J. W., Rinaldo, C. R., Jr., Gupta, P., White, R. M., Todd, J. A., and Kingsley, L. A. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170